The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Involvement of pp60c-src with two major signaling pathways in human breast cancer.
Open accessAbstract
The phosphotyrosine residues of receptor tyrosine kinases serve as unique binding sites for proteins involved in intracellular signaling, which contain SRC homology 2 (SH2) domains. Since overexpression or activation of the pp60c-src kinase has been reported in a number of human tumors, including primary human breast carcinomas, we examined the interactions of the SH2 and SH3 domains of human SRC with target proteins in human carcinoma cell lines. Glutathione S-transferase fusion proteins containing either the SH2, SH3, or the entire SH3/SH2 region of human SRC were used to affinity purify tyrosine-phosphorylated proteins from human breast carcinoma cell lines. We show here that in human breast carcinoma cell lines, the SRC SH2 domain binds to activated epidermal growth factor receptor (EGFR) and p185HER2/neu. SRC SH2 binding to EGFR was also observed in a nontumorigenic cell line after hormone stimulation. Endogenous pp60c-src was found to tightly associate with tyrosine-phosphorylated EGFR. Association of the SRC SH2 with the EGFR was blocked by tyrosyl phosphopeptides containing the sequences surrounding tyrosine-530, the regulatory site in the SRC C terminus, or sequences surrounding the major sites of autophosphorylation in the EGFR. These results raise the possibility that association of pp60c-src with these receptor tyrosine kinases is an integral part of the signaling events mediated by these receptors and may contribute to malignant transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
SH2 domains recognize specific phosphopeptide sequences
Zhou, S. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,631
SH2 and SH3 Domains: Elements that Control Interactions of Cytoplasmic Signaling Proteins
Koch, C. A., Anderson, D., Moran, M. F., Ellis, C., & Pawson, T. (1991) · Science · doi:10.1126/science.1708916 · Cited by 1,868
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
Schechter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I., & Weinberg, R. A. (1984) · Nature · doi:10.1038/312513a0 · Cited by 1,175
Association between the PDGF receptor and members of the src family of tyrosine kinases
Kypta, R. M., Goldberg, Y., Ulug, E. T., & Courtneidge, S. A. (1990) · Cell · doi:10.1016/0092-8674(90)90013-5 · Cited by 635
Semba, K., Kamata, N., Toyoshima, K., & Yamamoto, T. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6497 · Cited by 598
Ottenhoff-Kalff, A. E., Rijksen, G., van Beurden, E. A., Hennipman, A., Michels, A. A., & Staal, G. E. J. (1992) · PubMed · Cited by 348
Filmus, J., Pollak, M. N., Cailleau, R., & Buick, R. N. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)90131-7 · Cited by 338
Margolis, B. L., Lax, I., Kris, R., Dombalagian, M., Honegger, A. M., Howk, R., Givol, D., Ullrich, A., & Schlessinger, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81674-x · Cited by 211
Regulation of c-Src tyrosine kinase activity by the Src SH2 domain.
Liu, X. J., Brodeur, S. R., Gish, G., Songyang, Z., Cantley, L. C., Laudano, A. P., & Pawson, T. J. (1993) · PubMed · Cited by 206
Ralston, R., & Bishop, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.7845 · Cited by 203
Walton, G. M., Chen, W. S., Rosenfeld, M. G., & Gill, G. N. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40080-x · Cited by 192
Roussel, R. R., Brodeur, S. R., Shalloway, D., & Laudano, A. P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10696 · Cited by 171
Luttrell, D. K., Luttrell, L. M., & Parsons, S. J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.497-501.1988 · Cited by 149
Self-citationBiological effect of epidermal growth factor on the in vitro growth of human tumors.
Singletary, S. E., Baker, F. L., Spitzer, G., Tucker, S. L., Tomasovic, B., Brock, W. A., Ajani, J. A., & Kelly, A. M. (1987) · PubMed · Cited by 145
Wilson, L. K., Luttrell, D. K., Parsons, J. T., & Parsons, S. J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1536 · Cited by 107
Self-citationAnderson, S. K., Gibbs, C. P., Tanaka, A., Kung, H. J., & Fujita, D. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.5.1122 · Cited by 98
Twamley, G. M., Kypta, R. M., Hall, B. S., & Courtneidge, S. A. (1992) · PubMed · Cited by 89
Tanaka, A., Gibbs, C. P., Arthur, R., Anderson, S. K., Kung, H. J., & Fujita, D. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1978 · Cited by 79
Structural Basis of Interactions Between Epidermal Growth Factor Receptor and SH2 Domain Proteins
Sierke, S. L., Longo, G. M., & Koland, J. G. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1182 · Cited by 23
Wilson, L. K., Luttrell, D. K., Parsons, J. T., & Parsons, S. J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1536-1544.1989 · Cited by 23
Self-citationAnderson, S. K., Gibbs, C. P., Tanaka, A., Kung, H., & Fujita, D. J. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.5.1122-1129.1985 · Cited by 22
Tanaka, A., Gibbs, C. P., Arthur, R., Anderson, S. K., Kung, H. J., & Fujita, D. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1978-1983.1987 · Cited by 18
Cited by
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
“In addition, activation of c-Src also occurs with elevated frequency during progression of human breast cancer (Ottenho - Kal et al., 1992) and has been associated with constitutive activation of HER1 and HER2 proteins (Luttrell et al., 1994; Muthuswamy and Muller, 1995).”
BackgroundConstitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205260 · Cited by 1,207
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 959
Role of Src expression and activation in human cancer
Irby, R. B., & Yeatman, T. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203912 · Cited by 857
Src family kinases in tumor progression and metastasis
Summy, J. M., & Gallick, G. E. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023772912750 · Cited by 827
Metadata
- Authors
- Luttrell, D. K., Lee, A., Lansing, T. J., Crosby, R. M., Jung, K. D., Willard, D., Luther, M., Rodriguez, M., Berman, J., & Gilmer, T. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-01-04
- Volume
- 91
- Issue
- 1
- Pages
- 83-87
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2091656640
- Cited by
- 271
- References
- 25
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.